FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/10/075051 [Registered on: 10/10/2024] Trial Registered Prospectively
Last Modified On: 18/02/2025
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Other (Specify) [safety and efficacy study]  
Study Design  Randomized, Crossover Trial 
Public Title of Study   An exploratory clinical study to evaluate changes in lipid profile in healthy human subjects following consumption of potato chips fried in cottonseed oil versus Refined Palmolein oil.  
Scientific Title of Study   An Exploratory, Interventional, Prospective, Randomized, Cross-Over, Two-Arm, Clinical Study to evaluate the safety of Test Food(s) (i.e. Potato Chips Fried in Cotton Seed Oil Vs. Potato Chips Fried in Refined Palmolein Oil) on lipid profiles in Healthy Human Subjects.  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NB240050-HH 1.0, 19Sep 24  Protocol Number 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Jigar Patel  
Designation  Principal Investigator 
Affiliation  NovoBliss Research Private Limited 
Address  NovoBliss Research Pvt. Ltd. Office# A - 206, 2nd Floor, Shaligram Lakeview Business Complex, Nr. Vaishnodevi Circle, Khoraj, Gandhinagar

Gandhinagar
GUJARAT
382421
India 
Phone  9909013286  
Fax    
Email  consultant@novobliss.in  
 
Details of Contact Person
Scientific Query
 
Name  Dr Nayan Patel 
Designation  Sub- Investigator  
Affiliation  NovoBliss Research Private Limited 
Address  NovoBliss Research Pvt. Ltd. Office# A - 206, 2nd Floor, Shaligram Lakeview Business Complex, Nr. Vaishnodevi Circle, Khoraj, Gandhinagar

Gandhinagar
GUJARAT
382421
India 
Phone  9909013286  
Fax    
Email  dr.nayan@novobliss.in  
 
Details of Contact Person
Public Query
 
Name  Maheshvari Patel 
Designation  Director Operations and Strategic Management 
Affiliation  NovoBliss Research private Limited 
Address  NovoBliss Research Pvt. Ltd. Office# A - 206, 2nd Floor, Shaligram Lakeview Business Complex, Nr. Vaishnodevi Circle, Khoraj, Gandhinagar

Gandhinagar
GUJARAT
382421
India 
Phone  9909013286  
Fax    
Email  maheshvari@novobliss.in  
 
Source of Monetary or Material Support  
Tirupati agrotech private limited 7th Floor, popular house, ashram road Ahmedabad, Gujarat 380009  
 
Primary Sponsor  
Name  Tirupati agrotech private limited  
Address  7th floor, popular house, ashram road Ahmedabad, Gujarat 380009  
Type of Sponsor  Other [Food and agrotech] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NA 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Nayan Patel  NovoBliss Research Pvt. Limited  clinical trial department, office A 206, NovoBliss Research Pvt. Limited Office# A - 206, 2nd Floor, Shaligram Lakeview Business Complex, Nr. Vaishnodevi Circle, Khoraj, Gandhinagar 382421, Gujarat – India Gandhinagar GUJARAT
Gandhinagar
GUJARAT 
9909013286

dr.nayan@novobliss.in 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
ACEAS – Independent Ethics Committee,  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  Healthy Human Volunteers  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Nil   NA 
Intervention  Test Food A: Potato Chips fried in Cotton Seed oil  Mode of Usage: Subjects will consume 100 g of potato chips at morning breakfast, following at least 12 hours fasting period, with the intake to be completed within 15 minutes. Route of Administration- Orally Frequency - once a day Dose: 100 g of potato chips Dosage Form: solid Day of Administration: Day 02 and Day 05 
Intervention  Test Food B: Potato Chips fried in Refined Palmolein oil  Mode of Usage: Subjects will consume 100 g of potato chips at morning breakfast, following at least 12 hours fasting period, with the intake to be completed within 15 minutes. Route of Administration- Orally Frequency - once a day Dose: 100 g of potato chips Dosage Form: solid Day of Administration: Day 02 and Day 05 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  1)Age: Adults: 18 to 65 years (both inclusive) at the time of consent 2)Sex: Adults (males and non-pregnant or non-lactating females). 3)Females of childbearing potential should have a self-reported negative urine pregnancy test. 4)Subjects are generally in good general health as determined from a recent medical history, except for the atopic dermatitis.5)Subjects having stable weight for greater or equal to 3 month before the study. 6)Subjects are not allowed to participate in any other study until this study is complete. 7)Subjects must be willing and able to follow the study directions and to return for all specified visits with the subject.8)Subjects willing to follow the study instruction and restrictions. 9)Subject must read, sign, and receive a copy of Informed Consent prior to initiate of study procedures.
 
 
ExclusionCriteria 
Details  1)Subjects who use of lipid-lowering medication.2)Subjects having history of CVD. 3)Subjects having type 1 or type 2 diabetes.4)Subjects having hypertension. 5)Subjects having sensitivity towards taste and smell of oil. 6)Subjects having history of gastrointestinal disorders. 7)Subjects that are pregnant and/or breastfeeding. 8)Change in current prescriptions (within 4 weeks of screening) or new and/or additional prescriptions for dyslipidaemia (within 4 weeks of screening) or during the study. 9)The subject must not have participated in a clinical study within 4 weeks prior to the screening visit of this study. 10)Any other condition which could warrant exclusion from the study, as per the study physician. 11)History of chronic illness which may influence the study results.

 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Centralized 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To evaluate the safety of the test foods in terms of
1. change in lipid profile before and after consumption of the food
2.change in CBC, biochemistry, random blood sugar, uric acid, urinalysis before and after consumption of the test food
 
Within 7 days from Day 01, after 12 hours of fasting on Day 01 and further 04 hours of fasting at Day 01, and on Day 02 and Day 05
2.Within 07 days from Day 01, and on Day 05
 
 
Secondary Outcome  
Outcome  TimePoints 
Nil   NA  
 
Target Sample Size   Total Sample Size="34"
Sample Size from India="34" 
Final Enrollment numbers achieved (Total)= "0"
Final Enrollment numbers achieved (India)="0" 
Phase of Trial   N/A 
Date of First Enrollment (India)   21/10/2024 
Date of Study Completion (India) Date Missing 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="0"
Months="0"
Days="7" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary
Modification(s)  

This exploratory, interventional, prospective, randomized, cross-over, two-period, two-arm clinical trial evaluated the safety and impact of potato chips deep-fried in refined Cottonseed oil versus potato chips deep fried in refined Palmolein oil on lipid profiles in healthy adults aged 18 to 65 years. A total of 34 participants were enrolled and completed the study, which was registered with the Clinical Trial Registry of India (CTRI/2024/10/075051) on October 10, 2024. Subjects were screened by the NovoBliss Research screening department following Ethics Committee approved protocol standards and internal standard operating procedures.

Study Procedure and Methodology

The study was conducted over three distinct periods to assess the effects of Cottonseed oil consumption on lipid metabolism. Each period followed a structured protocol, including fasting conditions, sample collection, and data analysis, ensuring a rigorous and standardized approach.

Day 01 (Period I): Baseline Assessment

On the first day of the study, subjects arrived at the clinical site after a mandatory 12-hour overnight fast to ensure accurate baseline lipid profile measurements. Fasting blood samples (0-hour) were collected to establish baseline lipid levels before any dietary intervention. A second blood sample was drawn 4 hours post-fasting to evaluate natural lipid metabolism in the absence of any test food intake. Throughout the period, any adverse events (AEs) and concomitant medications were carefully documented to ensure participant safety and data integrity.

Day 02 (Period II): Test Food Consumption and Lipid Profile Evaluation

Following another 12-hour overnight fast, subjects returned to the clinical site for their second round of assessments. Baseline fasting lipid profile samples were collected before administering the assigned test food, determined based on a randomized allocation. Subjects then consumed the test food as per the study protocol. After ingestion, a post-consumption lipid profile sample was collected 4 hours later to assess acute changes in lipid metabolism. Any adverse events or medical concerns were closely monitored and documented throughout the process.

Day 05 (Period III): Washout Period and Repeat Assessment

After a three-day washout period, designed to minimize any carryover effects from the previous test food intake, subjects underwent a final assessment. Procedures from Period II were repeated, starting with a 12-hour overnight fast, followed by baseline lipid profile collection. Participants again consumed the assigned test food, and post-consumption blood samples were collected 4 hours later to measure lipid profile variations. Additionally, safety laboratory parameters, including hematological and biochemical markers, were assessed to ensure no adverse effects from dietary intervention.

Data Analysis and Statistical Considerations

All collected raw data underwent a thorough quality review before proceeding to statistical analysis. SPSS (Version 29.0.1.0(171)) and Microsoft Excel were used for data processing and interpretation. Statistical significance was set at a 5% level (p < 0.05) to ensure a robust and reliable evaluation of the findings. The structured methodology ensured that the results were both scientifically rigorous and clinically relevant, providing valuable insights into the effects of Cottonseed oil consumption on lipid metabolism.

The findings of this study highlight the potential health benefits and safety of incorporating refined Cottonseed oil into the diet, particularly through its use in deep-frying potato chips. A single consumption of Cottonseed oil demonstrated a favorable impact on lipid profile modulation, evidenced by a significant increase in HDL cholesterol levels and a slight reduction in LDL cholesterol levels—both key factors in maintaining optimal cardiovascular health.

Given these promising results, it can be hypothesized that the exclusive and prolonged use of Cottonseed oil may yield more robust clinical data, further reinforcing its potential as a heart-friendly dietary oil. In-vitro analysis of Cottonseed oil revealed its high linoleic acid content, which has been associated with improved cardiovascular health, reduced inflammation, and better overall fat quality. These attributes make Cottonseed oil a superior choice for frying, particularly when compared to Palmolein oil, which is often linked to higher saturated fat content and less favorable lipid metabolism effects.

Importantly, the study also found that the consumption of Cottonseed oil did not lead to any significant alterations in hematological, biochemical, or renal parameters, confirming its safety for regular dietary use. The observed changes in lipid profiles remained stable and within the normal laboratory range, suggesting no adverse effects on overall health.

Based on these findings, potato chips fried in Cottonseed oil emerge as a safe and potentially beneficial option for consumption, especially for individuals seeking to support cardiovascular health. Future studies with extended durations and larger sample sizes may provide deeper insights into its long-term benefits and clinical significance.


 
Close